Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0OZ4F
|
|||
Former ID |
DIB007760
|
|||
Drug Name |
Ordopidine
|
|||
Synonyms |
ACR-321; ACR-325
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Psychotic disorder [ICD-11: 6A20-6A25] | Discontinued in Phase 1 | [1] | |
Company |
A Carlsson Research AB
|
|||
Structure |
Download2D MOL |
|||
Formula |
C14H20FNO2S
|
|||
Canonical SMILES |
CCN1CCC(CC1)C2=C(C(=CC=C2)S(=O)(=O)C)F
|
|||
InChI |
1S/C14H20FNO2S/c1-3-16-9-7-11(8-10-16)12-5-4-6-13(14(12)15)19(2,17)18/h4-6,11H,3,7-10H2,1-2H3
|
|||
InChIKey |
UKUPJASJNQDHPH-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 871351-60-9
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025217) | |||
REF 2 | The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression. J Neural Transm. 2014 Nov;121(11):1337-47. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.